5 ms·
If we can do it this fast and this safely for COVID, we should do the same for this disease.
by rzz3 5y ago
If we can do it this fast and this safely for COVID, we should do the same for this disease.
- grayfaced 5y agoEfficacy trials are quick for a disease with 100k infections a day. It's much slower for something that has that many cases a year. It's much harder to tell a statistical difference from noise when you're talking minuscule cases in trial groups.